Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 16, 2026
TickeronGET DAILY SIGNALS
ESCO Technologies (ESE): A Closer Look at Its Niche Industrial Portfolio

ESCO Technologies (ESE): A Closer Look at Its Niche Industrial Portfolio

Key Takeaways

  • ESCO Technologies Inc. (ESE) is a St. Louis, Missouri-based manufacturer of highly engineered products and systems for aerospace, defense, utility, and industrial markets.
  • The company was spun off from Emerson Electric in 1990 and now operates through three segments: Aerospace & Defense, Utility Solutions Group, and RF Test & Measurement.
  • ESCO generates revenue through a mix of product sales, engineered projects, recurring aftermarket and service income, and software-and-monitoring offerings for electric utilities.
  • The company serves long-cycle end markets such as U.S. Navy shipbuilding, commercial aerospace, and electric grid modernization, supported by well-known subsidiaries including Doble Engineering and ETS-Lindgren.
  • Investors follow ESE for its diversified niche franchises, high barriers to entry, and exposure to secular themes in defense and energy infrastructure.

Introduction

ESCO Technologies Inc. (ESE) operates as a global supplier of engineered products and solutions across technically demanding markets. Rather than focusing on one core offering, it functions as a collection of specialized industrial businesses that cover aerospace and defense components, diagnostic equipment for electric utilities, and radio frequency test and measurement systems. Many of its products are qualified or specified for critical applications, which supports recurring revenue and creates meaningful switching costs for customers. This setup makes the company worth following for those interested in defense and infrastructure exposure.

Company Profile and History

ESCO Technologies was incorporated in Missouri in 1990 after being spun off from Emerson Electric via a shareholder distribution in October of that year, at which point it began trading on the New York Stock Exchange under the ticker ESE. Headquartered in St. Louis, the company employs about 3,400 people, and its fiscal year ends on September 30. Over time, management has reshaped the business through acquisitions and divestitures, moving away from legacy contracting toward higher-margin engineered products. Key steps include the 2015 purchase of Doble Engineering and the growth of ETS-Lindgren in electromagnetic compatibility testing. The company now reports results across three segments.

Aerospace & Defense

This segment focuses on specialty filtration and fluid-control products, precision-machined components, and naval signature-management and power systems. Subsidiaries such as PTI Technologies, Crissair, Mayday Manufacturing, Westland Technologies, and Globe Composite Solutions supply items like hydraulic filter elements, valves, and actuators for commercial and military aircraft, submarines, satellites, and missile systems. Many components go through lengthy qualification processes and remain in production for extended periods, which helps sustain repeat business.

Utility Solutions Group

Led by Doble Engineering along with Morgan Schaffer and NRG Systems, this segment offers diagnostic testing instruments, software, and services that allow electric grid operators to evaluate high-voltage equipment. It also includes tools for renewable energy uses such as wind resource assessment. Revenue here comes from a combination of product sales and recurring elements like service, calibration, and software subscriptions.

RF Test & Measurement

Through ETS-Lindgren, ESCO provides products and facilities for measuring and containing magnetic, electromagnetic, and acoustic energy. These include RF shielded rooms, anechoic chambers, antennas, and integrated test systems used for compliance, research, and wireless device testing. This segment tends to be more project-oriented, which can lead to greater revenue variability from one period to the next.

Business Model and Financial Profile

The company combines manufactured products, engineered projects, aftermarket parts, and service-and-monitoring revenue. Its approach centers on holding leadership positions in defensible niches, pursuing disciplined acquisitions, and building recurring aftermarket and service streams. In fiscal 2024, ESCO reported roughly $1.03 billion in sales, with most revenue coming from U.S. customers and additional contributions from Asia, Europe, and Canada. Because no single peer matches all three segments, the company competes against different groups in each market. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Why Investors Follow ESE

From what I see, investors track ESE for its diversified exposure to long-cycle markets with high barriers to entry. In aerospace and defense, qualified components in aircraft, submarine, and space programs often provide multi-year visibility. In utilities, grid modernization and renewable integration continue to drive demand for diagnostic and monitoring solutions. In RF test, growing wireless device use and stricter compliance needs support ongoing demand for test infrastructure. These themes, paired with a record of careful capital allocation, help underpin the company’s longer-term position.

Risks and Important Considerations

Several factors deserve attention. Revenue has some linkage to U.S. defense budgets and procurement timing, so changes in Department of Defense priorities or delays in naval and aerospace programs could influence results. The RF Test & Measurement segment is project-based and can fluctuate from quarter to quarter. The company also faces competition in its niches, potential supply-chain and labor constraints, and sensitivity to conditions in commercial aerospace and industrial markets. Valuation, as always, can shift with changes in growth expectations and interest rates.

Conclusion

ESCO Technologies presents itself as a diversified mid-cap industrial company centered on specialized franchises in aerospace and defense, electric utility diagnostics, and RF test and measurement. Its role in qualified, hard-to-replace product categories, along with recurring service and aftermarket revenue, supports its ongoing relevance. While it carries the typical risks of its industries, ESCO offers a clear example of a business model tied to durable trends in defense modernization and energy infrastructure.

Using AI Tools in My Research Process

In my research, I often turn to Tickeron's AI Screener to quickly scan thousands of stocks and ETFs. It helps surface ideas that align with specific strategies by combining technical indicators, fundamentals, volatility, trends, AI-generated signals, and customizable filters. This makes it a practical way to explore companies like ESCO Technologies or compare them against peers before digging deeper.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ESE

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


ESE's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for ESE turned positive on November 09, 2026. Looking at past instances where ESE's MACD turned positive, the stock continued to rise in 36 of 47 cases over the following month. The odds of a continued upward trend are 77%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ESE's RSI Indicator exited the oversold zone, 12 of 17 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 43 of 58 cases where ESE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.

Following a +6.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where ESE advanced for three days, in 213 of 347 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

ESE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ESE as a result. In 54 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ESE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.

The Aroon Indicator for ESE entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 39 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.

The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. ESE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.691) is normal, around the industry mean (1.448). P/E Ratio (18.917) is within average values for comparable stocks, (5.350). Projected Growth (PEG Ratio) (12.750) is also within normal values, averaging (5.470). Dividend Yield (0.001) settles around the average of (0.012) among similar stocks. P/S Ratio (5.208) is also within normal values, averaging (32.028).

The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Industry description

This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.

Market Cap

The average market capitalization across the Electronic Equipment/Instruments Industry is 7.99B. The market cap for tickers in the group ranges from 12.56K to 120.89B. KYCCF holds the highest valuation in this group at 120.89B. The lowest valued company is FLXT at 12.56K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Equipment/Instruments Industry was 5%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -13%. FCUV experienced the highest price growth at 130%, while ARAI experienced the biggest fall at -51%.

Volume

The average weekly volume growth across all stocks in the Electronic Equipment/Instruments Industry was 87%. For the same stocks of the Industry, the average monthly volume growth was 232% and the average quarterly volume growth was 107%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 50
Price Growth Rating: 61
SMR Rating: 78
Profit Risk Rating: 81
Seasonality Score: 6 (-100 ... +100)
1-on-1 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of engineering products and systems

Industry ElectronicEquipmentInstruments

Industry
Aerospace And Defense
Address
645 Maryville Centre Drive
Phone
+1 314 213-7200
Employees
3425
Web
https://www.escotechnologies.com
Interact to see
Advertisement
The central price target used here is $400 , roughly 35% above Alphabet's latest verified closing price of $295.77 (November 13, 2026). This target is the arithmetic mean of verified analyst price targets reviewed, not a single analyst's forecast; independent data providers report comparable consensus averages in the high-$390s to low-$400s.
Upcoming catalysts: Integration of advertising into AI Overviews and Gemini conversations, the scaling of Gemini 3 and newer models across Search and Cloud, and the commercial ramp of the $32 billion Wiz cloud-security acquisition could all shape sentiment into 2026. Strategic positioning: Alphabet's vertically integrated artificial intelligence (AI) stack — from custom TPU (Tensor Processing Unit) chips to the Gemini models to Google Cloud — supports a durable, cost-advantaged position in the AI build-out.
The TETH exchange-traded fund (ETF) is the 21Shares Ethereum Staking ETF, a spot Ethereum fund listed on Cboe BZX, and it does not carry conventional analyst price targets. The $14 objective used here is a technical milestone discussed in public market commentary — roughly the zone where Ethereum could begin confirming a recovery — not an analyst consensus.
The central target of $6.70 is the arithmetic mean of seven recent, individually verified analyst price targets, rounded from $6.67. At a latest price near $3.70, reaching $6.70 would require roughly 81% upside — a very large move.
Lead catalyst: Chemomab has secured alignment with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) on a single Phase 3 registration trial for nebokitug in primary sclerosing cholangitis (PSC), a rare liver disease with no approved disease-modifying therapy. Strategic pivot: A planned merger with Scipher Medicine is expected to close by year-end 2026, extending nebokitug into an AI-powered, precision-medicine Phase 2 trial in rheumatoid arthritis (RA).